biosimilar

(redirected from similar biological medicinal products)
Also found in: Medical.

bi·o·sim·i·lar

 (bī′ō-sĭm′ə-lər)
adj.
Highly similar in function and effect to an existing biological product, especially to a biologic that has already been clinically tested and approved for use.
n.
A biological product that is biosimilar to an existing product, especially to a biologic.
References in periodicals archive ?
Guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance: non-clinical and clinical issues.
32) EMA Procedural advice for users of Centralised Procedure for Similar Biological Medicinal Products applications, European Medicines Agency (Oct.
Guideline on similar biological medicinal products containing monoclonal antibodies (Draft), 18 November 2010, EMA/CHMP/ BMWP/403543/2010, European Medicines Agency, Committee for Medicinal Products for Human Use (CHMP).
et al (2008) Similar biological medicinal products containing recombinant human growth hormone: European regulation.
New provisions on generics and similar biological medicinal products also call for the definition of related fees.
EUROPEAN UNION: NEW DRAFT GUIDELINES ON SIMILAR BIOLOGICAL MEDICINAL PRODUCTS CONTAINING MONOCLONAL ANTIBODIES (MABS) AND IMMUNOGENICITY ASSESSMENT OF MABS INTENDED FOR IN VIVO CLINICAL USE